Drug intelligence / Profile preview

Gelaspan + Sterofundin ISO

Development stage
Unknown
Lead developer
B. Braun
Modality
Small Molecules
Administration
Intravenous
01

Overview

Gelaspan + Sterofundin ISO is a combination therapy used for intravenous fluid management, particularly in perioperative and critical care settings. It consists of two components: - **Gelaspan** is a 4% succinylated gelatin-based colloid solution designed for plasma volume replacement. It mimics physiological electrolyte composition to minimize metabolic disturbances and provides efficient intravascular volume expansion. - **Sterofundin ISO** is an isotonic, balanced crystalloid infusion containing sodium chloride, potassium chloride, magnesium chloride hexahydrate, calcium chloride dihydrate, sodium acetate trihydrate, and malic acid. Its electrolyte profile closely matches that of plasma to avoid hyperchloremia and metabolic acidosis. The combination aims to optimize hemodynamic stability by providing both rapid plasma volume expansion (via the colloid) and physiologically balanced electrolyte replenishment (via the crystalloid). This regimen has demonstrated benefits such as reduced metabolic derangement (less hyperchloremia and acidosis) compared to unbalanced solutions in surgical patients[1][5]. The mechanism of action involves direct intravascular volume expansion from gelatin polymers (colloid osmotic effect) alongside restoration of extracellular fluid balance with electrolytes.

Brand names
GelaspanSterofundin ISO
Other names
Gelaspan 4% + Sterofundin ISObalanced gelatine solution + balanced crystalloid solution

Beyond the preview

Go deeper on Gelaspan + Sterofundin ISO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gelaspan + Sterofundin ISO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call